Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Yuhua TianDepartment of Pharmacology, School of Pharmacy, Qingdao University, Qingdao 266071, China.ORCID 0000-0001-8239-6560
Soohyeon BaeDepartment of Brain Sciences, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu 42988, Korea.
Xuesong WuDepartment of Dermatology, University of California Davis, Sacramento, CA 95816.
Kyle C RouenDepartment of Physiology and Membrane Biology, School of Medicine, University of California, Davis, CA 95616.ORCID 0000-0001-8684-0614
Adriana Hernández-GonzalezDepartment of Physiology and Membrane Biology, School of Medicine, University of California, Davis, CA 95616.ORCID 0009-0006-3235-442X
Yanxiao HanDepartment of Physiology and Membrane Biology, School of Medicine, University of California, Davis, CA 95616.
Abdullah Al TekreetiDepartment of Physiology and Membrane Biology, School of Medicine, University of California, Davis, CA 95616.
Simon VuDepartment of Physiology and Membrane Biology, School of Medicine, University of California, Davis, CA 95616.
Irene ChenDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720.ORCID 0009-0009-4408-6735
Ellen LiCarlmont High School, Belmont, CA 94002.
Igor VorobyovDepartment of Physiology and Membrane Biology, School of Medicine, University of California, Davis, CA 95616.ORCID 0000-0002-4767-5297
Vladimir Yarov-YarovoyDepartment of Physiology and Membrane Biology, School of Medicine, University of California, Davis, CA 95616.ORCID 0000-0002-2325-4834
Byung-Chang SuhDepartment of Brain Sciences, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu 42988, Korea.ORCID 0000-0003-0278-2459
Samuel T HwangDepartment of Dermatology, University of California Davis, Sacramento, CA 95816.
Jie ZhengDepartment of Physiology and Membrane Biology, School of Medicine, University of California, Davis, CA 95616.ORCID 0000-0002-4161-627X
Funding
In silico Safety PharmacologyR01HL128537 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CLANCY, COLLEEN E, SANTANA, LUIS F · 2016 to 2024
$5.7M
Deep-learning methods based computational modelingR01NS128180 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Juan Du, VLADIMIR M YAROV-YAROVOY · 2022 to 2026
$3.3M
Digital Twins from the Atom to the RhythmR01HL174001 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI COLLEEN E CLANCY, Luis F Santana · 2024 to 2026
$2.4M
Investigation of state-specific drug binding to cardiac ion channels to reveals mechanisms of arrhythmogenesisF31HL174025 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ROUEN, KYLE C · 2024 to 2025
$84k
American Heart Association (AHA) 25CDA1450133HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) F31HL174025HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL128537HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL174001HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS128180National Research Foundation of Korea (NRF) RS-2025-02216189NHLBI NIH HHS F31 HL174025NHLBI NIH HHS R01 HL128537NHLBI NIH HHS R01 HL174001NINDS NIH HHS R01 NS128180
6 · The paper itself
Abstract
Temperature-sensitive transient receptor potential melastatin subfamily 4 (TRPM4) ion channels convert intracellular calcium increases into membrane depolarization, thereby linking these two powerful cellular signaling pathways in diverse physiological processes. TRPM4 mutations cause severe human hereditary cardiovascular and skin diseases; mysteriously, while these mutations are gain-of-function in nature, they affect the heart and the skin in a mutually exclusive manner. Here, we show that phosphatidylinositol 4,5-bisphosphate (PIP2) lipid is a required cofactor for TRPM4 activity by tightly regulating its calcium sensitivity. We detected two PIP2 binding sites and located the high-affinity site adjacent to the S4-S5 linker. We demonstrated that skin disease-associated TRPM4 mutations relieve the tight control of PIP2, resulting in elevated channel activity but only at the body surface temperature. In contrast, heart diseases are associated with mutations known to boost the number of channels, an effect we found to be annihilated by channel desensitization outside the body core. Indeed, dendritic cells from transgenic mice carrying a skin disease mutant exhibited elevated migration at 25-to-30°C range compared to those from normal mice, but no difference was observed at 37°C. These findings shed light on a molecular mechanism for dynamic regulation of cellular signaling in physiology and diseases.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Heat- and PIP2-dependent TRPM4 activity underlies mutually exclusive human diseases. · full record | OpenQuestion